Cargando…

Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019

This cross-sectional study uses Centers for Medicare & Medicaid Services payment data to examine use of short-course radiotherapy from 2015 to 2019 among Medicare beneficiaries with indolent lymphoma.

Detalles Bibliográficos
Autores principales:	Tringale, Kathryn R., Hubbeling, Harper, Chino, Fumiko, Hajj, Carla, Yahalom, Joachim, Imber, Brandon S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250056/ https://www.ncbi.nlm.nih.gov/pubmed/35977221 http://dx.doi.org/10.1001/jamahealthforum.2022.1815

Ejemplares similares

Medicare Spending on Drugs With Accelerated Approval, 2015-2019
por: Rome, Benjamin N., et al.
Publicado: (2021)

Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study
por: Qi, Shunan, et al.
Publicado: (2022)

Radiotherapy of Follicular Lymphoma: Updated Role and New Rules
por: Yahalom, Joachim
Publicado: (2014)

State-Level Variation in Medicare Spending
por: Gage, Barbara, et al.
Publicado: (1999)

Prescription Drug Coverage and Spending for Medicare Beneficiaries
por: Poisal, John A., et al.
Publicado: (1999)

Outpatient prescription drug spending by the Medicare population
por: Waldo, Daniel R.
Publicado: (1987)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
por: Essa, Mohammed, et al.
Publicado: (2023)

State Public Assistance Spending and Survival Among Adults With Cancer
por: Barnes, Justin M., et al.
Publicado: (2023)

The impact of weight loss among seniors on Medicare spending
por: Thorpe, Kenneth E, et al.
Publicado: (2013)

Medicare physicians' services: The composition of spending and assignment rates
por: Burney, Ira, et al.
Publicado: (1985)

Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Estimated Annual Spending on Aducanumab in the US Medicare Program
por: Mafi, John N., et al.
Publicado: (2022)

Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
por: Parikh, Ravi B., et al.
Publicado: (2022)

DataView: Medicare Spending by State: The Border-Crossing Adjustment
por: Basu, Joy, et al.
Publicado: (1995)

Drug Coverage, Utilization, and Spending by Medicare Beneficiaries with Heart Disease
por: Sharma, Ravi, et al.
Publicado: (2003)

Association of Medicare Spending With Subspecialty Consultation for Elderly Hospitalized Adults
por: Ryskina, Kira L., et al.
Publicado: (2019)

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
por: Kyle, Michael Anne, et al.
Publicado: (2022)

Chemotherapy only in early-stage Hodgkin lymphoma: More relapses but “same” (or possibly worse) survival – Reconsidering the misguided trend to omit radiotherapy
por: Yahalom, Joachim
Publicado: (2014)

Association Between Medicare Star Ratings for Patient Experience and Medicare Spending per Beneficiary for US Hospitals
por: Trzeciak, Stephen, et al.
Publicado: (2017)

Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis
por: Schwartz, Aaron L., et al.
Publicado: (2021)

Analysis of Prescriptions Dispensed After Death and Associated Medicare Spending Following Reimbursement Policy Changes in Medicare
por: Vouri, Scott M., et al.
Publicado: (2023)

Association of Mental Health Disorders With Health Care Spending in the Medicare Population
por: Figueroa, Jose F., et al.
Publicado: (2020)

Social Determinants of Health and Geographic Variation in Medicare per Beneficiary Spending
por: Zhang, Yongkang, et al.
Publicado: (2021)

Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D
por: Trish, Erin, et al.
Publicado: (2021)

Trends in and Factors Contributing to the Slowdown in Medicare Spending Growth, 2007-2018
por: Buntin, Melinda B., et al.
Publicado: (2022)

Medicare spending associated with a dementia diagnosis among older adults
por: Hoffman, Geoffrey J., et al.
Publicado: (2022)

Changes in spending, utilization, and quality of care among Medicare accountable care organizations during the COVID-19 pandemic
por: Yan, Brandon W., et al.
Publicado: (2022)

Changes in Medicare Accountable Care Organization Spending, Utilization, and Quality Performance 2 Years Into the COVID-19 Pandemic
por: Yan, Brandon W., et al.
Publicado: (2023)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019
por: Troy, Aaron, et al.
Publicado: (2021)

Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012
por: Hernandez, Inmaculada, et al.
Publicado: (2017)

A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers?
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2021)

Associations between Hospital Quality Outcomes and Medicare Spending per Beneficiary in the USA
por: Cook, Karyn, et al.
Publicado: (2021)

1416. Medicare Spending on Urinary Tract Infections: A Retrospective Database Analysis
por: Sulham, Kate, et al.
Publicado: (2021)

The impact of Medicaid expansion on spending and utilization by older low‐income Medicare beneficiaries
por: Mellor, Jennifer M., et al.
Publicado: (2023)

Changes in Out-of-Pocket Spending and Catastrophic Health Care Expenditures Associated With Medicare Eligibility
por: Scott, John W., et al.
Publicado: (2021)

Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market
por: Dean, Emma Boswell, et al.
Publicado: (2021)

Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists
por: Dickson, Sean R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b0pn1h5md5abu6ku6l0aublig3